Pair feeding-mediated changes in metabolism: Stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 6, 2008, Pages

  Russell, James C ^a   Proctor, Spencer D ^a   Kelly, Sandra E ^a   Brindley, David N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fatty acids; Metabolic syndrome; Myocardial lesions; Stress; Vascular function

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL; FATTY ACID; PHENYLEPHRINE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CONTROLLED STUDY; FATTY ACID OXIDATION; GLUCOSE METABOLISM; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; STRESS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; BODY WEIGHT; CYTOCHEMISTRY; DISEASE MODEL; DRUG EFFECT; EATING; EXERCISE; FOOD DEPRIVATION; GLUCOSE BLOOD LEVEL; HEART MUSCLE; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PHYSIOLOGY; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BODY WEIGHT; DISEASE MODELS, ANIMAL; EATING; FATTY ACIDS, NONESTERIFIED; FOOD DEPRIVATION; HISTOCYTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MUSCLE CONTRACTION; MYOCARDIUM; PHENYLEPHRINE; RATS; RESTRAINT, PHYSICAL; STRESS; TRIGLYCERIDES; VASOCONSTRICTOR AGENTS;

EID: 47549101235     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90257.2008     Document Type: Article

References (57)

1. Absher PM, Schneider DJ, Baldor LC, Russell JC, Sobel BE. The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo. Atherosclerosis 143: 245-251, 1999.
2. Absher PM, Schneider DJ, Russell JC, Sobel BE. Increased proliferation of explanted vascular smooth muscle cells: a marker presaging atherogenesis. Atherosclerosis 131: 187-194, 1997.
3. Atkinson LL, Kelly SE, Russell JC, Bar-Tana J, Lopaschuk GD. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR:LA-cp rats. Diabetes 51: 1548-1555, 2002.
4. Atkinson LL, Kozak R, Kelly SE, Onay-Besikci A, Russell JC, Lopaschuk GD. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Am J Physiol Endocrinol Metab 284: E923-E930, 2003.
5. Báez-Ruiz A, Escobar C, Aguilar-Roblero R, Vasquez-Martinez O, Diaz-Muñoz M. Metabolic adaptations of liver mitochondria during restricted feeding schedules. Am J Physiol Gastrointest Liver Physiol 289: G1015-G1023, 2005.
6. Björntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2: 79-86, 2001.
7. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
8. Brindley DN, Hales P, Al-Sieni AI, Russell JC. Sustained decreases in body weight and circulating insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats chronically treated with D-fenfluramine. Br J Pharmacol 105: 679-685, 1992.
9. Brindley DN, Hales P, Al-Sieni AI, Russell JC. Decreased serum lipids, serum insulin and triacylglycerol synthesis in adipose tissue of JCR:LA-corpulent rats treated with benfluorex. Biochim Biophys Acta 1085: 119-125, 1991.
10. Brindley DN, Rolland Y. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin Sci (Lond) 77: 453-461, 1989.
11. Chaouloff F, Laude D, Merino D, Serrurier B, Eighozi JL. Peripheral and central consequences of immobilization stress in genetically obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 256: R435-R442, 1989.
12. Chau SC Jr, White DW, Wu-Peng XS, Liu SM, Okada N, Kershaw EE, Chung WK, Power-Kehoe L, Chua M, Tartaglia LA, Leibel RL. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 45: 1141-1143, 1996.
13. Chenin I, Shimabukuro M, Yamakawa K, Higa N, Matsuzaki T, Noguchi K, Ueda S, Sakanashi M, Takasu N. Vascular lipotoxicity: endothelial dysfunction via fatty acid-induced reactive oxygen species overproduction in obese Zucker Diabetic Fatty rats. Endocrinology 148: 160-165, 2007.
14. Clarke SD, Romsos DR, Leveille GA. Influence of dietary fatty acids on liver and adipose tissue lipogenesis and on liver metabolites in meal-fed rats. J Nutr 107: 1277-1287, 1977.
15. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol Endocrinol Metab Gastrointest Physiol 235: E97-E102, 1978.
16. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957, 1996.
17. Elam MB, Wilcox HG, Cagen LM, Deng X, Raghow R, Kumar P, Heimberg M, Russell JC. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res 42: 2039-2048, 2001.
18. Ide T, Nakazawa T, Mochizuki T, Murakami K. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats. Metabolism 49: 521-525, 2000.
19. Iso H, Date C, Yamamoto A, Toyoshima H, Tanabe N, Kikuchi S, Kondo T, Watanabe Y, Wada Y, Ishibashi T, Suzuki H, Koizumi A, Inaba Y, Tamakoshi A, Ohno Y. Perceived mental stress and mortality from cardiovascular disease among Japanese men and women: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC Study). Circulation 106: 1229-1236, 2002.
20. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 30: 1104-1106, 1997.
21. Leza JC, Salas E, Sawicki G, Russell JC, Radomski MW. The effect of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther 286: 1397-1403, 1998.
22. Makino S, Baker RA, Smith MA, Gold PW. Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants. J Neuroendocrinol 12: 387-395, 2000.
23. Malabu UH, Dryden S, McCarthy HD, Kilpatrick A, Williams G. Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding. Diabetes 43: 9-15, 1994.
24. Marshall SM, Flyvjerg A. Prevention and early detection of vascular complications of diabetes. BMJ 333: 475-480, 2006.
25. Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebral vascular systems. J Nutr Biochem 16: 129-137, 2005.
26. McArthur MD, Graham SE, Russell JC, Brindley DN. Exaggerated stress-induced release of non-esterified fatty acids in JCR:LA-corpulent rats. Metabolism 47: 1383-1390, 1998.
27. O'Brien SF, Russell JC. Insulin resistance and vascular wall function: lessons from animal models. Endocrinol Metab 4: 155-162, 1997.
28. Ozelci A, Romosos DR, Leveille GA. Influence of diet composition on nitrogen balance and body composition in meal-eating and nibbling rats. J Nutr 107: 1768-1774, 1977.
29. Pickavance LC, Wilding JP. Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty rat. Diabetes Obes Metab 9: 114-120, 2007.
30. Proctor SD, Kelly SE, Russell JC. A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats. Diabetologia 48: 1925-1932, 2005.
31. Proctor SD, Vine DF, Mamo JC. Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol 24: 2162-2167, 2004.
32. Proctor SD, Russell JC. Small animal models of cardiovascular disease: tools for study of roles of the metabolic syndrome, dyslipidemias and atherosclerosis. Cardiovasc Pathol 15: 318-330, 2006.
33. Radomski MW, Salas E. Nitric oxide - biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 118: S69-S80, 1995.
34. Richardson M, Schmidt AM, Graham SE, Achen B, DeReske M, Russell JC. Vasculopathy and insulin resistance in the JCR:LA-cp rat. Atherosclerosis 138: 135-146, 1998.
35. Rupp H, Maisch B, Brilla CG. Schedule-induced psychological stress and molecular structures of cardiomyocytes. Am J Physiol Regul Integr Comp Physiol 272: R776-R782, 1997.
36. Russell JC, Graham SE, Richardson M. Cardiovascular disease in the JCR:LA-cp rat. Mol Cell Biochem 188: 113-126, 1998.
37. Russell JC, Graham SE, Dolphin PJ, Brindley DN. Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat. Can J Physiol Pharmacol 74: 879-886, 1996.
38. Russell JC, Kelly SE, Schäfer S. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat. J Cardiovasc Pharmacol 44: 258-265, 2004.
39. Russell JC, Kelly SE, Shäfer S. Insulin-sensitizing and cardiovascular effects of the sodium-hydrogen exchange inhibitor, cariporide, in the JCR:LA-cp rat. J Cardiovasc Pharmacol 46: 746-753, 2005.
40. Russell JC, Koeslag DG, Amy RM, Dolphin PJ. Plasma lipid secretion and clearance in the hyperlipidemic JCR:LA-corpulent rat. Arteriosclerosis 9: 869-876, 1989.
41. Russell JC, McKendrick JD, Dubé GP, Dolphin PJ, Radomski MW. Effects of LY117018 and the estrogen analogue, 17alpha-ethinylestradiol, on vascular reactivity, platelet aggregation, and lipid metabolism in the insulin-resistant JCR:LA-cp rat: role of nitric oxide. J Cardiovasc Pharmacol 37: 119-128, 2001.
42. Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta,beta′-tetramethylhexadecanedioic acid (MEDICA 16). Atheroscler Thromb Vasc Biol 15: 918-923, 1995.
43. Russell JC, Bar-Tana J, Shillabeer G, Lau DC, Richardson M, Wenzel LM, Graham SE, Dolphin PJ. Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes 47: 770-778, 1998.
44. Russell JC, Dolphin PJ, Graham SE, Amy RM, Brindley DN. Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine. Diabetologia 41: 380-389, 1998.
45. Russell JC, Graham S, Hameed M. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 43: 538-543, 1994.
46. Russell JC, Graham SE, Dolphin PJ, Brindley DN. Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat. Can J Physiol Pharmacol 74: 879-886, 1996.
47. Russell JC, Graham SE, Dolphin PJ. Glucose tolerance and insulin resistance in the JCR:LA-cp rat: effect of miglitol (Bay m1099). Metabolism 48: 701-706, 1999.
48. Russell JC, Graham SE, Richardson M. Cardiovascular disease in the JCR:LA-cp rat. Mol Cell Biochem 188: 113-126, 1998.
49. Russell JC, Proctor SD. Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats. Br J Pharmacol 151: 216-225, 2007.
50. Satoh Y, Kawai N, Kudo N, Kawashima Y, Mitsumoto A. Time-restricted feeding entrains daily rhythms of energy metabolism in mice. Am J Physiol Regul Integr Comp Physiol 290: R1276-R1283, 2006.
51. Vance JE, Russell JC. Hypersecretion of VLDL, but not HDL, by hepatocytes from the JCR:LA-corpulent rat. J Lipid Res 31: 1491-1501, 1990.
52. Vine DF, Takechi R, Russell JC, Proctor DF. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis 190: 282-290, 2007.
53. Walder K, Filippis A, Clark S, Zimmet P, Collier GR. Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol 155: R5-R7, 1997.
54. Wan R, Camandola S, Mattson MP. Dietary supplementation with 2-deoxy-D-glucose improves cardiovascular and neuroendocrine stress adaptation in rats. Am J Physiol Heart Circ Physiol 287: H1186-H1193, 2004.
55. Williams G, Shellard L, Lewis DA, McKibbin PE, McCarthy HD, Koeslag D, Russell JC. Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA-corpulent rat. Peptides 13: 537-540, 1992.
56. Wu-Peng XS, Chua SC, Okada N, Liu SM, Nicolson M, Leibel RL. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 46: 513-518, 1997.
57. Zanchi A, Dulloo AG, Perregaux C, Montani JP, Burnier M. Telmisartan prevents glitazone-induced weight gain without interfering with its insulin-sensitizing properties. Am J Physiol Endocrinol Metab 293: E91-E95, 2007.